Neuronetics: Q4 Earnings Snapshot
Posted March 7, 2023 7:48 am.
Last Updated March 7, 2023 8:02 am.
MALVERN, Pa. (AP) — MALVERN, Pa. (AP) — Neuronetics Inc. (STIM) on Tuesday reported a loss of $8.3 million in its fourth quarter.
The Malvern, Pennsylvania-based company said it had a loss of 30 cents per share.
The medical device company focused on psychiatric disorders posted revenue of $18.2 million in the period.
For the year, the company reported a loss of $37.2 million, or $1.38 per share. Revenue was reported as $65.2 million.
For the current quarter ending in March, Neuronetics said it expects revenue in the range of $15 million to $16 million.
The company expects full-year revenue in the range of $66 million to $72 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on STIM at https://www.zacks.com/ap/STIM
The Associated Press